Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Best practices for veterinary toxicologic clinical pathology, with emphasis on the pharmaceutical and biotechnology industries.
- Lindsay Tomlinson, L. Boone, +12 authors D. Bounous
- Medicine
- Veterinary clinical pathology
- 1 September 2013
The purpose of this paper by the Regulatory Affairs Committee (RAC) of the American Society for Veterinary Clinical Pathology (ASVCP) is to review the current regulatory guidances (eg, guidelines)… Expand
Reducing blood volume requirements for clinical pathology testing in toxicologic studies-points to consider.
- F. Poitout-Belissent, A. Aulbach, N. Tripathi, L. Ramaiah
- Medicine
- Veterinary clinical pathology
- 1 December 2016
In preclinical safety assessment, blood volume requirements for various endpoints pose a major challenge. The goal of this working group was to review current practices for clinical pathology (CP)… Expand
Biomarkers in Nonclinical Drug Development
- A. Aulbach, C. Amuzie
- Medicine
- 2017
Abstract In the context of nonclinical drug development, a biomarker may be defined as any specific parameter that is objectively measured and evaluated as an indicator of normal biological… Expand
Optimized Processing of Fine-Needle Lymph Node Biopsies for Automated Immunostaining
- A. Aulbach, C. Swenson, M. Kiupel
- Biology, Medicine
- Journal of veterinary diagnostic investigation…
- 1 May 2010
A straightforward, reliable technique for postcollection processing and evaluation of cytologic specimens for antigen detection using an automated immunostainer was developed. Visual assessment of… Expand
Influence of Study Design Variables on Clinical Pathology Data
- A. Aulbach, Anne Provencher, N. Tripathi
- Medicine
- Toxicologic pathology
- 1 February 2017
A number of factors related to study design have the potential to impact clinical pathology test results during the conduct of nonclinical safety studies. A thorough understanding of these factors is… Expand
Cytological Bone Marrow Cell Differential Counts and Morphologic Findings in Healthy Cynomolgus Monkeys (Macaca fascicularis) from Nonclinical Toxicology Studies
- Caitlyn M Carter, Laura C. Cregar, A. Aulbach
- Biology, Medicine
- Toxicologic pathology
- 1 February 2017
Cytological bone marrow evaluation is utilized in nonclinical toxicology studies to characterize hematopoietic effects when the combined interpretation of histologic and complete blood count data… Expand
Overview and considerations for the reporting of clinical pathology interpretations in nonclinical toxicology studies.
- A. Aulbach, Allison Vitsky, +11 authors L. Boone
- Medicine
- Veterinary clinical pathology
- 1 September 2019
Clinical pathology reporting practices are diverse among individuals and organizations involved in nonclinical toxicology studies. Clear, informative, and consistent reporting of clinical pathology… Expand
Factors affecting urine reagent strip blood results in dogs and nonhuman primates and interpretation of urinalysis in preclinical toxicology studies: a Multi-Institution Contract Research…
- A. Aulbach, Eric Schultze, N. Tripathi, R. Hall, M. R. Logan, D. J. Meyer
- Medicine
- Veterinary clinical pathology
- 1 June 2015
BACKGROUND
Urinalysis data in preclinical toxicology studies can be influenced by preanalytic and analytic factors which have the potential to confound interpretation. There is a paucity of… Expand
Interpretative considerations for clinical pathology findings in nonclinical toxicology studies.
- A. Aulbach, Allison Vitsky, +11 authors L. Boone
- Medicine
- Veterinary clinical pathology
- 1 September 2019
The interpretation of clinical pathology results from nonclinical safety studies is a fundamental component in hazard identification of new drug candidates. The ever-increasing complexity of… Expand
Deciphering Sources of Variability in Clinical Pathology
- N. Tripathi, N. Everds, +4 authors A. Aulbach
- Medicine
- Toxicologic pathology
- 1 January 2017
The objectives of this session were to explore causes of variability in clinical pathology data due to preanalytical and analytical variables as well as study design and other procedures that occur… Expand